@article{5ac9aaf335af44ae9ecf596ccca3e7b8,
title = "Chromatin-modifying enzymes as modulators of reprogramming",
author = "Onder, {Tamer T.} and Nergis Kara and Anne Cherry and Sinha, {Amit U.} and Nan Zhu and Bernt, {Kathrin M.} and Patrick Cahan and Marcarci, {B. Ogan} and Juli Unternaehrer and Gupta, {Piyush B.} and Lander, {Eric S.} and Armstrong, {Scott A.} and Daley, {George Q.}",
note = "Funding Information: Acknowledgements We thank G. Hu and S. J. Elledge for providing the MSCV-PM vector, K. Ng and M. W. Lensch for teratoma injections and assessment and S. Loewer for discussions. We also thank E. Olhava and Epizyme Inc. for synthesizing and providing the DOT1L inhibitor, EPZ004777. G.Q.D. is an investigator of the Howard Hughes Medical Institute. Research was funded by grants from the US National Institutes of Health (NIH) to S.A.A. (CA140575) and G.Q.D., and the CHB Stem Cell Program.",
year = "2012",
month = mar,
day = "29",
doi = "10.1038/nature10953",
language = "English",
volume = "483",
pages = "598--602",
journal = "Nature",
issn = "0028-0836",
number = "7391",
}